Document is current
Any future updates will be listed below
-
Authors
Ouerdani, Aziz
Valenzuela, Belén
Treijtel, Nicoline
Haddish-Berhane, Nahor
Desphande, Sanjay
Srinivasan, Srimathi
Smith, Emma
Perez Ruixo, Juan José
-
Funding
Funding for this research was provided by:
Janssen Research & Development, LLC
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 14 January 2025
First Online: 28 February 2025
Declarations
:
: A Ouerdani, B Valenzuela, N Haddish-Berhane, S Desphande, E Smith and JJ Perez Ruixo are employees of Johnson & Johnson and hold stocks of Johnson & Johnson, except for N Treijtel who is a contracted employee. S Srinivasan is an ex-employee of Johnson & Johnson (employed by Johnson & Johnson at the time of the study); she is currently working with Merck, USA.
: All authors were employees and shareholders of Janssen Pharmaceutical Companies at the time this analysis was conducted (except for N Treijtel who was a contracted employee and not a shareholder).
